Baird raised the firm’s price target on Genpact (G) to $52 from $50 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact’s Strong Financial Performance and Strategic Advancements Drive Buy Rating
- Genpact price target raised to $53 from $50 at Needham
- Genpact Reports Strong Q2 2025 Financial Results
- Genpact’s Strong Performance and Strategic Positioning Drive Buy Rating
- Genpact sees Q3 adjusted EPS 89c-90c, consensus 88c